Sun Pharmaceutical Industries Ltd. (SUNPHARMA) - Financials, balance sheet (quarterly)

1,672 INR

9.5

0.57%

Last update Jul 11, 3:29 PM IST

Market closed

Day range

1,672

1,662.19995

1,679.90002

Previous close

1,662.5

Open

1,665.80005

Access this stock data via API

Sun Pharmaceutical Industries Ltd.

1,672.00

9.50

0.57%

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Sep 2023
Total assets	921.0B	881.2B	854.6B	794.4B
Current assets	526.2B	461.1B	434.7B	393.5B
Cash	—	—	24.4B	—
Cash equivalents	—	—	68.4B	—
Cash and cash equivalents	102.7B	80.1B	92.9B	54.0B
Other short term investments	164.6B	127.4B	100.4B	103.6B
Accounts receivable	130.5B	129.4B	112.5B	113.0B
Other receivables	483.8M	474M	801.3M	431.1M
Inventory	102.4B	99.4B	98.7B	99.6B
Prepaid assets	—	—	27.9B	—
Restricted cash	—	—	151.6M	—
Assets held for sale	304.1M	366M	418.7M	211.5M
Hedging assets	—	—	349.5M	—
Other current assets	25.3B	23.9B	646.7M	22.6B
Non current assets	394.8B	420.1B	419.9B	400.9B
Properties	100.4B	101.0B	101.9B	101.0B
Land and improvements	—	—	10.5B	—
Machinery furniture equipment	—	—	149.2B	—
Construction in progress	12.3B	11.5B	11.1B	10.2B
Leases	—	—	—	—
Accumulated depreciation	—	—	-125.8B	—
Goodwill	269.0B	269.9B	258.6B	267.1B
Investment properties	—	—	—	—
Financial assets	—	—	0	—
Intangible assets	90.2B	94.5B	86.7B	88.7B
Investments and advances	—	—	—	—
Other non current assets	5.4B	4.7B	4.7B	4.6B
Total liabilities	196.1B	187.4B	183.6B	162.4B
Current liabilities	181.9B	172.6B	169.8B	150.2B
Accounts payable	61.8B	57.3B	56.5B	57.0B
Accrued expenses	—	—	—	—
Short term debt	20.0B	22.0B	29.7B	16.1B
Deferred revenue	—	—	—	—
Tax payable	7.3B	5.9B	4.1B	4.6B
Pensions	—	—	6.8B	—
Other current liabilities	11.7B	7.0B	9.6B	6.6B
Non current liabilities	14.2B	14.8B	13.7B	12.2B
Long term provisions	4.7B	4.0B	141.7M	3.6B
Long term debt	3.6B	3.7B	3.0B	3.1B
Provision for risks and charges	87.6M	—	—	—
Deferred liabilities	1.9B	1.9B	1.6B	356.6M
Derivative product liabilities	—	—	0	—
Other non current liabilities	3.9B	4.6B	112M	5.1B
Shareholders equity
Common stock	2.4B	2.4B	2.4B	2.4B
Retained earnings	—	—	501.5B	—
Other shareholders equity	—	—	—	—
Total shareholders equity	724.9B	693.8B	671.1B	632.0B
Additional paid in capital	—	—	11.9B	—
Treasury stock	—	—	—	—
Minority interest	2.7B	2.6B	34.4B	33.7B